DJIA 17,687.54 9.31 0.05%
NASDAQ 4,875.07 11.71 0.24%
S&P 500 2,057.57 1.42 0.07%
market minute promo

Rexahn Pharmaceuticals (NYSEMKT: RNN)

0.72 -0.01 (-1.00%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

RNN $0.72 -1.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.74
Previous Close $0.72
Daily Range $0.72 - $0.74
52-Week Range $0.65 - $1.29
Market Cap $128.1M
P/E Ratio -6.56
Dividend (Yield) $0.00 (0.0%)
Volume 225,701
Average Daily Volume 599,302
Current FY EPS -$0.11

Sector

Healthcare

Industry

Drug Makers

Rexahn Pharmaceuticals (RNN) Description

Rexahn Pharmaceuticals Inc. is a clinical stage biopharmaceutical company developing and seeking to deliver novel cures for cancer and disorders of the central nervous system (CNS) to patients worldwide. Website: http://www.rexahn.com/

News & Commentary

This Week in Biotech: NW Bio Soars While Geron Goes Geronimo

Two early-stage study results, a rare hospital exemption approval in Germany, and a devastating full clinical hold for one biotech are among this week's top biotech stories.

UPDATE: MLV & Co Initiates Coverage On Rexahn Pharmaceuticals On Oncology Pipeline With Strategic Fl

UPDATE: MLV & Co Initiates Coverage On Rexahn Pharmaceuticals On Oncology Pipeline With Strategic Flexibility

Onxeo: An Upcoming Mid-Sized Pharma With Ambitions

Rexahn's Lead Drug RX-3117 Beats Lilly's Gemzar In One-To-One Face Off

Rexahn Pharmaceuticals (RNN) Jumps: Stock Rises 12.5% - Tale of the Tape

Can The Uptrend Continue for Rexahn Pharmaceuticals (RNN)? - Tale of the Tape

Update: Rexahn Likens Partnership With Demonstrated Potential Of RX-3117

Why Rexahn Pharmaceuticals (RNN) Could Be Positioned for a Surge? - Tale of the Tape

Rexahn Pharmaceuticals (RNN): Strong Industry, Solid Earnings Estimate Revisions - Tale of the Tape

Update: Rexahn Q3 Earnings, Bull Thesis Reiterated

Events for the Week of Nov. 17-21, 2014

See More RNN News...

RNN's Top Competitors

RNN $0.72 (-1.00%)
Current stock: RNN
AMGN $162.57 (1.26%)
Current stock: AMGN
GILD $101.84 (0.76%)
Current stock: GILD
BIIB $434.78 (1.36%)
Current stock: BIIB